Skip to content
The Policy VaultThe Policy Vault

Xarelto — Medical Mutual

Deep Vein Thrombosis (DVT) in Patients Undergoing Hip or Knee Replacement Surgery, Prophylaxis

Reauthorization criteria

  • Response to therapy is required for continuation unless otherwise noted

Approval duration

60 days